| Value | ₹216.4 Cr |
|---|
BSE filing, NSE: FREDUN. Summary written from the filing by ALFA Finder's alert engine.
Fredun Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,505.00
- Market cap
- ₹2,157 Cr
- Revenue (annual)
- ₹635.5 Cr
- Net profit (annual)
- ₹32.62 Cr
- P/E (TTM)
- 49.2×Sector 41.3×
- Promoter holding
- 43.62%-0.95% QoQ
- FII holding
- 0.69%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fredun Pharmaceuticals Ltd
All →Fredun Pharmaceuticals Board Meeting Date
Fredun Pharmaceuticals will hold a board meeting on 05 November 2026 to consider half-year results. Trading window stays closed until 48 hours after results.
Fredun Pharmaceuticals Convertible Warrants
Fredun Pharmaceuticals allotted 44,000 equity shares to three non-promoter investors on conversion of 14,667 warrants. The conversion follows the 1:2 bonus issue, which adjusted warrant entitlements.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026. The disclosure provides the equity holding structure for shareholders.
Fredun Pharmaceuticals Other Announcement
Fredun Pharmaceuticals filed a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. It confirms the processing of dematerialized shares for the quarter.
Fredun Pharmaceuticals Business Update
Fredun Pharma announces strategic pet-care acquisitions, capacity expansion, and a 100% branded portfolio target by 2029. H1 FY27 business update outlines multi-pillar growth transformation.
- manufacturing infrastructure (Palghar plant)
- 90000 sq. ft.
Fredun Pharmaceuticals Capital Structure Change
Fredun Pharmaceuticals allotted 1,82,400 equity shares upon the conversion of 60,800 warrants. The company received total consideration of ₹7.60 Crore for this warrant conversion.
- Value
- ₹7.60 Cr
Other debt & borrowing announcements
All →Godrej Properties Debt & Borrowing: ₹100 Cr
Godrej Properties Limited has redeemed Commercial Papers worth Rs. 100 Crore. The company extinguished 2,000 securities of face value Rs. 5,00,000 each upon maturity.
- Value
- ₹100.0 Cr
Persistent Systems Debt & Borrowing: ₹7,000 Cr
Persistent Systems Limited approved the allotment of 700,000 non-convertible debentures (NCDs) aggregating to ₹7,000 Crore. The senior rated debt, issued on a private placement basis, carries an 8.95% coupon.
- Value
- ₹7,000 Cr
- Execution
- 2 to 3 years
Hindustan Petroleum Corporation Debt & Borrowing: ₹191 Cr
HPCL paid Rs.191 Crore interest on its 7.64% Series IV NCDs due 4 November 2026. The payment relates to a Rs.2,500 Crore issue.
- Value
- ₹191.0 Cr
Arman Financial Services Debt & Borrowing: ₹387.3 Cr
Arman Financial Services Ltd submitted its asset cover certificate for the quarter ended September 30, 2026. The company maintains a 110% security cover on its outstanding secured non-convertible debentures.
- Value
- ₹387.3 Cr
Bajaj Housing Finance Debt & Borrowing: ₹3,003 Cr
Bajaj Housing Finance allotted 3,00,000 secured NCDs aggregating Rs. 3,002.68 crore via private placement. The 10-year debentures carry an 8.68% annual coupon maturing in November 2036.
- Value
- ₹3,003 Cr
CL Educate Debt & Borrowing: ₹100 Cr
CL Educate issues secured NCDs worth ₹100 Crore at 11.90% p.a. over 50 months. The debentures are listed on BSE's wholesale debt segment.
- Value
- ₹100.0 Cr
- Execution
- 50 months (2026-11-25 to 2031-01-25)